Clinical Trial Update: PTX3-targeted Antifungal Prophylaxis [NA]

View source ↗

Summary

A clinical trial is recruiting to evaluate PTX3-targeted antifungal prophylaxis for preventing candidiasis and other fungal infections, including aspergillosis.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Aspergillosis
• Candidiasis

Drugs mentioned

• PTX3-targeted antifungal prophylaxis

Snippet

Sponsor: Bochud Pierre-Yves | Conditions: Candidiasis, Fungal Infection | NA | Status: RECRUITING